[HTML][HTML] Clinical expert consensus on the assessment and protection of pancreatic islet β-cell function in type 2 diabetes mellitus
J Zhu, J Han, L Liu, Y Liu, W Xu, X Li, L Yang… - Diabetes Research and …, 2023 - Elsevier
Islet β-cell dysfunction is a basic pathophysiological characteristic of type 2 diabetes mellitus
(T2DM). Appropriate assessment of islet β-cell function is beneficial to better management of …
(T2DM). Appropriate assessment of islet β-cell function is beneficial to better management of …
Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: a population-based observational study
Background Lifetime glycemic exposure and its relationship with age at diagnosis in type 2
diabetes (T2D) are unknown. Pharmacologic glycemic management strategies for young …
diabetes (T2D) are unknown. Pharmacologic glycemic management strategies for young …
[HTML][HTML] Initial Combination Therapy in Type 2 Diabetes
JY Kim, NH Kim - Endocrinology and Metabolism, 2024 - synapse.koreamed.org
Abstract Type 2 diabetes (T2D) is a progressive disease in which it is challenging to achieve
long-term durable glycemic control. However, intensive glycemic control is crucial for …
long-term durable glycemic control. However, intensive glycemic control is crucial for …
Insulin resistance and beta‐cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 …
Aims We investigated quantitative expression, mutual aggregation and relation with
hyperglycemia of insulin resistance (IR) and beta‐cell dysfunction (BCD) in newly …
hyperglycemia of insulin resistance (IR) and beta‐cell dysfunction (BCD) in newly …
Case report: a Chinese family of Woodhouse-Sakati syndrome with diabetes mellitus, with a novel biallelic deletion mutation of the DCAF17 gene
Woodhouse–Sakati syndrome (WSS)(OMIM# 241080) is a rare multi-system autosomal
recessive disease with homozygous mutation of the DCAF17 gene. The main features of …
recessive disease with homozygous mutation of the DCAF17 gene. The main features of …
[HTML][HTML] Reg 蛋白家族在糖尿病中的研究现状
郑亚莲， 杨刚毅 - Advances in Clinical Medicine, 2024 - hanspub.org
糖尿病(Diabetes Mellitus, DM) 是一种全球流行病, 随着生活水平的提高及全球老龄化, DM
患病率越来越高, 成为世界范围内主要的健康负担. 胰岛β 细胞功能受损和数量减少是糖尿病 …
患病率越来越高, 成为世界范围内主要的健康负担. 胰岛β 细胞功能受损和数量减少是糖尿病 …
Basal insulin reduces glucose variability and hypoglycaemia compared to premixed insulin in type 2 diabetes patients: a study based on continuous glucose …
H Wang, Y Zhou, Y Wang, T Cai, Y Hu, T Jing… - Frontiers in …, 2022 - frontiersin.org
Aims To examine the glycaemic variability and safety of basal and premixed insulin by using
continuous glucose monitoring (CGM) systems. Methods 393 patients with type 2 diabetes …
continuous glucose monitoring (CGM) systems. Methods 393 patients with type 2 diabetes …
Impact of Type 2 Diabetes Duration on the Efficacy and Safety of Add-on Lixisenatide in Asian Individuals Receiving Basal Insulin: A Pooled Analysis
J Yao, M Zhang, X Zhang, J Zhang - Diabetes Therapy, 2023 - Springer
Introduction This analysis investigated the efficacy and safety of add-on lixisenatide by
disease duration in Asian people with type 2 diabetes inadequately controlled with basal …
disease duration in Asian people with type 2 diabetes inadequately controlled with basal …
Outcomes and Management of Type 2 Diabetes in India and China
C Ke - 2021 - search.proquest.com
Nearly half of all the adults with diabetes worldwide live in India and China. This thesis
examines various aspects of the management and outcomes of type 2 diabetes mellitus in …
examines various aspects of the management and outcomes of type 2 diabetes mellitus in …